COVID-19肺炎后1年肺部损伤的胸部CT表现:CovILD研究
本研究为前瞻性多中心观察性队列的二次分析,对91例COVID-19肺炎患者在症状出现后约1年行胸部CT,采用CT严重度评分(CTSS)评估。54%的患者1年时仍存在CT异常,年龄>60岁、男性、危重型COVID-19与持续异常相关;随访中CTSS降低(P<.001),49%的患者完全吸收,但63%有异常者在6个月后未再进一步改善。
要点
- COVID-19肺炎后1年,54%(49/91)患者胸部CT仍可见异常,其中20%为广泛磨玻璃影、网格影、支气管扩张或微囊变。
- 年龄>60岁、男性、危重型COVID-19与1年时持续CT异常独立相关(OR分别为5.8、8.9、29)。
- 63%(31/49)有CT异常者在6个月后未再进一步改善,提示部分病变可能长期残留。
核心结论
- COVID-19肺炎后1年胸部CT异常常见,高龄、男性及危重型患者更易出现持续异常;CTSS在随访中总体降低,但部分患者6个月后不再改善。
研究设计与样本
- 前瞻性多中心观察性队列研究的二次分析,2020年4月29日至8月12日纳入142例,其中91例完成1年随访CT并纳入分析(平均年龄59岁±13,女性35例[38%]),采用定性CT严重度评分(CTSS,0–25分)评估。
关键影像表现/征象
- 1年时54%(49/91)存在CT异常,34%(31/91)表现为轻微胸膜下网格影、磨玻璃影或两者兼有,20%(18/91)表现为广泛磨玻璃影、网格影、支气管扩张、微囊变或其组合。
- 随访CT显示CTSS降低(P<.001),研究期间49%(69/142)患者CT异常完全吸收。
- 63%(31/49)有CT异常者在6个月后未见进一步改善。
诊断标准与关键数值
- CTSS采用定性分级,范围0分(正常)至25分(所有肺叶受累)。
- 多因素分析显示年龄>60岁(OR 5.8,95%CI 1.7–24,P=.009)、危重型COVID-19(OR 29,95%CI 4.8–280,P<.001)、男性(OR 8.9,95%CI 2.6–36,P<.001)与1年随访持续CT异常相关。
临床应用与阅片要点
- 对COVID-19肺炎康复者,尤其高龄、男性及危重型患者,1年随访CT仍可能见胸膜下网格影、磨玻璃影、支气管扩张或微囊变。
- CTSS可用于半定量评估随访中肺部异常的范围变化,但需注意约63%有异常者在6个月后已趋于稳定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The long-term pulmonary sequelae of COVID-19 is not well known. Purpose To characterize patterns and rates of improvement of chest CT abnormalities 1 year after COVID-19 pneumonia. Materials and Methods This was a secondary analysis of a prospective, multicenter observational cohort study conducted from April 29 to August 12, 2020, to assess pulmonary abnormalities at chest CT approximately 2, 3, and 6 months and 1 year after onset of COVID-19 symptoms. Pulmonary findings were graded for each lung lobe using a qualitative CT severity score (CTSS) ranging from 0 (normal) to 25 (all lobes involved). The association of demographic and clinical factors with CT abnormalities after 1 year was assessed with logistic regression. The rate of change of the CTSS at follow-up CT was investigated by using the Friedmann test. Results Of 142 enrolled participants, 91 underwent a 1-year follow-up CT examination and were included in the analysis (mean age, 59 years ± 13 [SD]; 35 women [38%]). In 49 of 91 (54%) participants, CT abnormalities were observed: 31 of 91 (34%) participants showed subtle subpleural reticulation, ground-glass opacities, or both, and 18 of 91 (20%) participants had extensive ground-glass opacities, reticulations, bronchial dilation, microcystic changes, or a combination thereof. At multivariable analysis, age of more than 60 years (odds ratio [OR], 5.8; 95% CI: 1.7, 24; P = .009), critical COVID-19 severity (OR, 29; 95% CI: 4.8, 280; P < .001), and male sex (OR, 8.9; 95% CI: 2.6, 36; P < .001) were associated with persistent CT abnormalities at 1-year follow-up. Reduction of CTSS was observed in participants at subsequent follow-up CT (P < .001); during the study period, 49% (69 of 142) of participants had complete resolution of CT abnormalities. Thirty-one of 49 (63%) participants with CT abnormalities showed no further improvement after 6 months. Conclusion Long-term CT abnormalities were common 1 year after COVID-19 pneumonia. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Leung in this issue.
引用
- Luger, Sonnweber, Gruber, et al. Chest CT of Lung Injury 1 Year after COVID-19 Pneumonia: The CovILD Study. Radiology. 2022. PMID: 35348379. doi:10.1148/radiol.211670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。